Work

Abstract 443: Blood-based genotyping and clinical outcomes in patients with advanced breast cancer receiving the CDK4/6 inhibitor palbociclib in real-world settings: Results from POLARIS

Year: 2019

Type: conference-abstract

Source: Clinical Research (Excluding Clinical Trials)

DOI: 10.1158/1538-7445.sabcs18-443

Authors: Aditya Bardia, Joanne L. Blum, Steven L. McCune, Kamal Patel, Richard C. Frank, Kailash Mosalpuria, Meghan S. Karuturi, Lloyd A. Shabazz, Gabrielle B. Rocque, Yuan Liu, Zhe Zhang, Jian Wang, Yao Wang, Debu Tripathy

Institutions: Harvard University, Massachusetts General Hospital, Central Arkansas Radiation Therapy Institute, Norwalk Hospital, Nebraska Hematology-Oncology, The University of Texas MD Anderson Cancer Center, Illinois CancerCare, University of Alabama at Birmingham, Pfizer (United States), Cytel (United States)

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2955529672

Cites:

Cited by:

Related to: 10